Methods of producing cell cysts and cell cyst tubes

By generating cell capsules and cell capsules in the 3D extracellular matrix and forming a tubular network, the problem of unknown cell migration mechanism in the 3D environment is solved, efficient directed transport of cells in complex microenvironment is achieved, and the treatment of various diseases is promoted. development.

CN118979006APending Publication Date: 2024-11-19CELLMIG BIOLABS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411065723.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2018-01-12
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

In 3D extracellular matrix, the mechanism of cell migration is not yet clear, and prior art is difficult to understand and regulate the movement and morphological changes of cells in complex microenvironments.

Method used

In a controlled 3D microenvironment, cell capsules and cell capsules are generated under incubation conditions by implanting cells into or on top of the 3D extracellular matrix, forming a tubular network to direct cell trafficking. Enhanced cap-dependent translation initiation and ITGB-2 protein expression promote the formation and elongation of cell capsules and cell capsule tubes.

Benefits of technology

Provides tools to understand the mechanisms of cell migration in the 3D microenvironment, helping to develop treatments for a variety of diseases such as tumor growth, metastasis, and drug resistance, significantly improving the efficiency and direction of cells in the 3D environment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004979294550000011
    Figure HDA0004979294550000011
  • Figure HDA0004979294550000021
    Figure HDA0004979294550000021
  • Figure HDA0004979294550000022
    Figure HDA0004979294550000022
Patent Text Reader

Abstract

The present invention provides methods and compositions for producing cell cysts and cell cyst tubes in a 3D matrix.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of a patent application with an application date of January 12, 2018, application number 201880015102.7, and invention name “Method for producing cell capsules and cell capsule tubes”. Technical Field

[0002] The present invention relates to the field of producing cell capsules and cell capsule tubes, and methods and compositions thereof. Background Art

[0003] Cell boundaries separate cells from the external environment, allowing and protecting intracellular activities and contents from adverse effects of environmental factors. Cell boundaries are essential for cell sensing, migration, invasion, relocation, proliferation, growth, differentiation, communication and response to the environment, intake of nutrients and oxygen, removal of metabolic wastes, and protection against environmental stress.

[0004] Cell movement in multicellular organisms has an important impact on embryonic development (Le Douarin NM (1984) Cell migrations in embryos. Cell 38(2): 353-360; Reig G, Pulgar E, & Concha ML (2014) Cell migration: from tissue culture to embryos. Development 141(10): 1999-2013; Richardson BE & Lehmann R (2010) Mechanisms guiding primordial germ cell migration: strategies from different organisms. Nat Rev Mol Cell Biol 11(1): 37-49) and organ homeostasis (Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, & Nieto MA (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. The Journal of clinical investigation 119(6):1438-1449), tissue regeneration(Bryant DM&Mostov KE(2008)From cells to organs:building polarized tissue.NatRev Mol Cell Biol 9(11):887-901), immune response(Woodland DL&Kohlmeier JE(2009)Migration, maintenance and recall of memory T cells in peripheral tissues.NatRev Immunol9(3):153-161; Weninger W, Biro M, & Jain R (2014) Leukocyte migration in the interstitial space of non-lymphoid organs.Nat Rev Immunol 14(4):232-246), wound repair (Gurtner GC, Werner S, Barrandon Y, & Longaker MT (2008) Wound repair and regeneration. Nature 453(7193):314-321) and tumor spread (Friedl P & Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147(5):992-1009; Friedl P & Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3(5):362-374; Barbolana MV, et al. (2009) Microenvironmental regulation of ovarian cancer metastasis. Cancer Treat Res 149:319-334). Cell migration in a three-dimensional (3D) microenvironment is subject to heterogeneous cells and extracellular matrix (ECM), which provide scaffolds and guidance cues for the direction of movement, while essentially forming environmental barriers that hinder cell movement (Thiery JP, Acloque H, Huang RY, & Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139 (5): 871-890; Franz CM, Jones GE, & Ridley AJ (2002) Cell migration in development and disease. Dev Cell 2 (2): 153-158). To facilitate movement, cells adaptively generate surface-attached organelles and compartments that change with time and space, including lamellipodia (Murphy DA & Courtneidge SA (2011) The'ins'and'outs'of podosomes and invadopodia: characteristics, formation and function.Nat Rev Mol Cell Biol 12(7):413-426), filopodia (Mattila PK&Lappalainen P (2008) Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol 9(6):446-454), podosome (Tarone G, Cirillo D, Giancotti FG, Comoglio PM, & Marchisio PC(1985)Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes.Exp Cell Res 159(1):141-157), invasive pseudopodia (Chen WT(1989)Proteolytic activity of specialized surfaceprotrusions formed at rosette contact sites of transformed cells.J Exp Zool251(2):167-185), Fackler OT&Grosse R(2008)Cell motility through plasma membrane blebbing.J Cell Biol 181(6):879-884;Ridley AJ(2011)Life at the leading edge.Cell 145(7):1012-1022), focal adhesions (Wehrle-Haller B(2012)Structure and function of focal adhesions.Current opinion in cell biology 24(1):116-124), dendritic pseudopods and type II epithelial bridges (Zani BG, Indolfi L, & Edelman ER(2010)Tubularbridges for bronchial epithelial cell migration and communication.PLoS One 5(1):e8930). Therefore, the mechanism of cell relocation in multicellular organisms is still unclear. .

[0005] Cell morphology, organelles used, and mechanisms and signal control in 3D cell migration are generally different from the corresponding features of 2D cell migration (Baker BM & Chen CS (2012) Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci 125(Pt 13): 3015-3024; Wu PH, Giri A, Sun SX, & Wirtz D (2014) Three-dimensional cell migration does not follow a random walk. Proceedings of the National Academy of Sciences of the United States of America 111(11): 3949-3954; Friedl P, Sahai E, Weiss S, & Yamada KM (2012) New dimensions in cell migration. Nat Rev Mol Cell Biol 13(11): 743-747). Cells moving in collagen-rich 3D matrices do not have lamellipodia or filopodia, but display highly dendritic pseudopodial protrusions, which are not present on the surface of rigid plates (Jayatilaka H, ​​et al. (2017) Synergistic IL-6 and IL-8 paracrine signalling pathway infers astrategy to inhibit tumour cell migration. Nature communications 8: 15584; Giri A, et al. (2013) The Arp2 / 3 complex mediates multigeneration dendritic protrusions for efficient 3-dimensional cancer cell migration. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 27(10): 4089-4099).

[0006] There is a continuing need in the art for methods and compositions that can be used to understand cell motility in 3D extracellular matrices and 3D microenvironments. Summary of the invention

[0007] The present disclosure addresses this need and is based on the discovery that cells in a controlled 3D microenvironment, such as a 3D extracellular matrix, can generate at least two types of novel membranous organelles, namely, cell capsules and cell capsule tubes. Cell capsule tubes provide tubular pathways for directional cell transport. Multiple cell capsule tubes are interconnected and form a tubular meshwork for directional cell transport in different directions. It has been found that enhanced cap-dependent translation initiation and increased expression of proteins including ITGB-2 are associated with the formation of cell capsules and cell capsule tubes and the elongation of cell capsule tubes. Methods and compositions for generating cell capsules and cell capsule tubes in a controlled 3D extracellular matrix provide a powerful tool for understanding the mechanisms of cell migration in a 3D microenvironment, which is a prerequisite for the development of effective treatments for a variety of diseases related to cell migration, cell sensing, cell stress protection, cell proliferation, cell differentiation, tumor growth, tumor development, tumor metastasis, tumor recurrence and drug resistance.

[0008] One aspect of the present disclosure provides a composition comprising a 3D extracellular matrix and cell capsules and cell capsule tubes. The cell capsules and cell capsule tubes are produced by cells implanted in the 3D matrix or on the top layer thereof.

[0009] Another aspect of the present disclosure provides a method for producing cell capsules and cell capsule tubes, which comprises implanting cells into a 3D matrix or a top layer thereof, and incubating the 3D matrix implanted with cells under conditions that enable the cells to generate cell capsules and cell capsule tubes.

[0010] Another aspect of the present invention provides a method for producing cell capsules and cell capsule tubes in vitro, which comprises the following steps: implanting cells in a single cell suspension onto the top layer of a 3D matrix; and culturing the 3D matrix implanted with cells under conditions that enable the cells to produce cell capsules and cell capsule tubes in the 3D matrix.

[0011] Another aspect of the present disclosure provides a method for preparing a 3D matrix suitable for producing cell capsules and cell capsule tubes, wherein the method comprises freezing the 3D matrix and thawing the 3D matrix at a suitable temperature.

[0012] It should be noted that in this disclosure, particularly in the claims and / or paragraphs, terms such as "comprising" may have the meaning ascribed to it in U.S. patent law; for example, it may mean "including"; and terms such as "consisting essentially of..." have the meaning ascribed to it in U.S. patent law, for example, it allows elements not expressly recited but excludes elements found in the prior art or that affect the basic or novel characteristics of the invention.

[0013] These aspects and other embodiments are disclosed or are obvious from and encompassed by the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] The patent or application file contains at least one drawing in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee. The foregoing features and other features and advantages of embodiments of the present invention will be more fully understood by the detailed description of illustrative embodiments in conjunction with the following drawings, in which:

[0015] Figures 1A-1F Images of the resulting cell capsule and cell capsule tube are depicted. Figure 1A Images of generated cell capsules and elongated cell capsule tubes are shown. Under the indicated conditions, human mammary epithelial cells (HMEC) were seeded on thick 3D Matrigel gels to generate membranous extracytoplasmic cell capsules and elongated cell capsule tubes. Fluorescent images of cell capsule tubes of a single HMEC transiently overexpressing EGFP-PMCA2 and mCherry-β-actin and showing cell capsule tubes are shown. HMEC (red arrow), cell capsule (CC, white arrow), cell capsule membrane (CCM, orange arrow) are shown. Figure 1B Quantitative analysis of cell capsule length is shown. Figure 1C Inverted phase contrast bright field microscopy images showing decellularization of the cell capsule. The blue arrow indicates that a single HMEC produces a large cell capsule (CC, red arrow) that encapsulates cells. After 1 hour, the HMEC leaves the cell capsule, leaving a decellularized cell capsule (eCC, white arrow) with no cells inside. The cell capsule membrane (CCM, orange arrow) is shown in the figure. Figure 1D A schematic diagram of cell capsule decellularization is shown. Figure 1E Quantification of cell capsule diameter size is shown. Figure 1F DIC images (left) and fluorescence images (right) of a large membranous cell capsule (CC, red arrow) are shown. Scale bar = 10 μm.

[0016] Figure 2 The meshwork structure of HMEC cell cysts is depicted. HMEC migration and meshwork formation in cell cysts. The figure shows cell cysts (CT, red arrows), cell cyst junction nodes (CTNs), multiple cells migrating in a single cell cyst (orange arrows), and cell clusters without cell cysts (black arrows).

[0017] Figure 3A-3B Depicts the structure of the cell cyst network. Figure 3A) Multiple BCSC cell capsules cross. Multiple BCSC cell capsules are interconnected through cell capsule nodes (CTNs) and form a cross morphology. Cells migrate in the cell capsule network. ( Figure 3B ) Radical morphology of BCSC cystic tube (CT, red arrow) network. Up to five cystic tubes are connected by cystic tube nodes (CTN). Multiple cells migrate in the cystic tube network with different morphologies. Scale bar = 10 μm.

[0018] Figure 4 Depicted is the live imaging of cell lysis analysis of the BCSC cell capsule network system. Bright field image of the cell capsule network obtained by live imaging of cell lysis. The nested cell capsules (CT, red arrows) and cell capsule nodes (CTN) in the cell capsule network are shown. Images were taken 1-2 seconds after cell lysis buffer treatment. At 3 seconds after lysis buffer treatment, all cell capsules and cytoplasmic membranes were lysed and disappeared.

[0019] Figure 5A-5G Depicted are cell capsule fusion and cell entry. Figure 5A ) Bright field image of the fused cell tubes of two cell tubes produced by two cells. Cell 2 is located in the fused cell tube. The image shows the fused cell tube (MTP, red arrow) and the fused cell tube membrane (MTM, orange arrow). ( Figure 5B ) DIC and fluorescence microscopy images of a fused macrocyst with multiple cells (cell clusters) located within the fused macrocyst. The fused macrocyst membrane (MTM, orange arrow) is shown. Figure 5C )Quantification of cells that entered. Figure 5D ) Immunofluorescence microscopy images of endogenous syncytin-1 in HMEC. Figure 5E ) Western blot images of syncytin-1 expression during cyst tube development. Fig. 5F ) Knockdown of syncytin-1 reduced the fusion of HMEC cell cyst tubes. Figure 5G ) Knockdown of syncytin-1 does not affect the initiation of HMEC cell cyst tube formation.

[0020] Figure 6A-6B Depicts ITGB-2 regulating the elongation of the cyst tube. Fig. 6A ) Heat map of transcriptional changes of 26 integrin genes during cyst tube development. Figure 6B ) Effects of ITGB-2 on cell cystogenesis and cell cyst tube elongation. DETAILED DESCRIPTION OF THE INVENTION

[0022] The disclosed aspects of the present invention are based on the observation that has not been discovered so far, that is, when cells are implanted and cultured in a controlled 3D extracellular matrix, two new extracellular membrane-like organelles can be produced, which are referred to as cell capsules and cell capsule tubes in the present invention. Cells migrate in cell capsules and produce cell capsule tubes, which show pleiotropic biological functions and provide tubular pathways for directional cell transport within the matrix. Multiple cell capsule tubes are formed and interconnected to produce a mesh structure that supports directional cell transport in different directions within the matrix. The present disclosure proposes a mechanism for directional cell migration based on cell capsule tubes in a 3D microenvironment. The methods and compositions currently disclosed for producing cell capsules and cell capsule tubes will help understand the mechanisms of embryonic development, organ homeostasis, tissue regeneration and immune response of multicellular organisms, as well as develop therapies for treating and manipulating a variety of diseases and biological processes, including but not limited to cell migration, cell perception, cell stress protection, cell proliferation, cell differentiation, tumor growth, tumor development, tumor metastasis, tumor recurrence and drug resistance.

[0023] As observed, the life cycle of the cell capsule and cell capsule tube produced in the 3D extracellular matrix in the method described in the present invention can be summarized as follows. In the initial step, a single / individual cell produces a small, round, extracellular and membranous cell capsule surrounding the cell. Subsequently, the cell capsule undergoes multiple development stages. In the first stage, the cell capsule undergoes decellularization. As a result of decellularization, the cell capsule is completely separated from the detached cell and becomes a cell-free cell capsule. The inventors also observed incomplete separation of the cell capsule and the detached cell. In the case of incomplete separation, the expelled cells remain connected to the cell-free cell capsule and can re-enter the connected cell-free cell capsule by self-entry and re-close the cell capsule with the cells in the lumen. In the second stage, the cell capsule grows and forms a large (diameter / major axis of about 100-250 μm), round or oval cell capsule. The large cell capsule can shrink slightly and form a shrinking cell capsule that surrounds the cells in the lumen. On the other hand, other cells from the surrounding environment can enter a single large cell capsule containing cells, thereby forming a single cell capsule containing multiple cells. The decellularization of these large cell capsules produces large cell-free cell capsules, which will shrink, deflate and form large deflated concave disks (or irregular morphologies). In the third stage, cells migrate in the cell capsule, deforming the cell capsule membrane and producing elongated cell capsule tubes. Alloentry of surrounding cells allows multiple cells to enter the cell capsule tube and migrate in the cell capsule tube. Cell migration (single cell or multi-cell) in homogeneous and membrane-enclosed cell capsule tubes is faster than cell migration in a heterogeneous environment composed of heterogeneous extracellular matrix (ECM) and other cells and structures. It is speculated that in the cell capsule tube, cell migration is not hindered by ECM, cells and structures. The cell capsule tubes are interconnected and form a branched, seamless and membranous tubular network structure, providing a tubular network system for the transport / movement of directional 3D cells in different directions. The decellularization process produces cell-free cell capsules and cell capsule tubes. All cell-free cell membranes and cell capsule tubes undergo rapid self-decomposition.

[0024] According to one aspect, the present invention provides a composition comprising a 3D extracellular matrix and a cell capsule and a cell capsule tube. In one embodiment, the cell capsule and the cell capsule tube are produced by a single cell implanted in or on the top layer of the 3D matrix. In one embodiment, the cells are implanted on the top surface of the 3D matrix. Prior to implantation, the cells are processed into a single cell suspension with a density of about 1×10 to about 1×10 5 cells / ml.

[0025] According to one aspect, the cell capsule and cell capsule tube surround the cells that produce the cell capsule and cell capsule tube. According to another aspect, the cell capsule and cell capsule tube include a plurality of cells that enter the cell capsule and cell capsule tube from the surrounding environment. According to another aspect, the cell capsule and cell capsule tube undergo decellularization and support the enclosed cells to form acellular cell capsule and cell capsule tube without cells.

[0026] According to certain aspects, the present invention provides a 3D matrix wherein a plurality of cells in a near single cell suspension are added to the 3D matrix or to a top layer thereof. Incubation of the cell-seeded 3D matrix under controlled conditions results in single cells generating cell capsules and cell capsule tubes.

[0027] According to one aspect, the 3D matrix is ​​porous. Porosity can be produced by polymerization and / or cross-linking of molecules for preparing the matrix material. Porosity is controlled by changing the percentage of branched monomers of cross-linking density, chain length and copolymerization according to methods known to those skilled in the art. According to one aspect, the 3D matrix is ​​porous so that additional reagents can diffuse or otherwise pass through the matrix. Porous matrix can be prepared according to methods known to those skilled in the art. Additional control of molecular sieve size and density is achieved by adding additional cross-linking agents (e.g., functionalized polyethylene glycol).

[0028] According to another aspect, the 3D matrix is ​​viscous. The viscosity of the 3D matrix may be adjusted according to any method known in the art.

[0029] According to one aspect, the 3D matrix material is chemically inert and is thermally stable to adapt to various temperatures. According to one aspect, the 3D matrix material is optically transparent. According to one aspect, the 3D matrix material is optically transparent, to be applicable to 3D imaging techniques known to those skilled in the art. According to one aspect, the matrix has enough optical transparency or has the optical properties suitable for the depth 3D imaging of high-throughput information readout.

[0030] According to one aspect, the material used to form the matrix is ​​biodegradable. According to another aspect, the material used to form the matrix is ​​compatible with various biological and non-biological in situ specimens.

[0031] According to one aspect, the material of matrix can be semi-solid culture medium, and it can be made of polyacrylamide, cellulose, alginate, polyamide, cross-linked agarose, cross-linked dextran or cross-linked polyethylene glycol.In some aspects, semi-solid culture medium can be attached to solid support, for example on microscope slide, culture plate or flow chamber.Solid support can be attached to the bottom surface of semi-solid culture medium.

[0032] The formation material of matrix includes but is not limited to polyacrylamide, cellulose, alginate, polyamide, cross-linked agarose, cross-linked dextran or cross-linked polyethylene glycol.The formation material of matrix can be formed by using the method for matrix formation material and method, reagent and condition known to those skilled in the art to polymerize and / or cross-link matrix formation material to form matrix.

[0033] The formation material of the matrix also includes but is not limited to elastin, laminin, proteoglycans (such as heparan sulfate, chondroitin sulfate and keratin sulfate) and non-proteoglycans (such as hyaluronic acid). In certain embodiments, the formation material of the matrix may also include proteins, including but not limited to fibrils, fiber-related collagen (Facit) of discontinuous triple helical structure, short chains and basement membrane proteins. In other embodiments, the formation material of the matrix may further include signaling proteins, including but not limited to local adhesion kinase (FAK), talin, vinculin, paxllin, α-actinin and GTPase. For example, biodegradable, biocompatible polymers can be used as matrix materials, including but not limited to ethylene vinyl acetate, polyanhydride, polyglycolic acid, collagen, polyorthoesters, polylactic acid and polylactic acid, polyglycolic acid copolymer (PLG).

[0034] According to some aspects, the matrix is ​​used in combination with a solid support. For example, the matrix can be polymerized in such a way that one surface of the matrix is ​​attached to a solid support (e.g., a glass surface), and another surface of the matrix is ​​exposed or sandwiched between two solid supports. According to one aspect, the matrix can be contained in a container.

[0035] Solid supports of the present disclosure can be made into various shapes. In certain embodiments, the solid support is substantially planar. Examples of solid supports include plates such as slides, microtiter plates, flow chambers, coverslips, microchips, containers such as microcentrifuge tubes, test tubes, tubes, sheets, pads, membranes, etc. In addition, the solid support can be, for example, biological, non-biological, organic, inorganic, or a combination thereof.

[0036] It has been found that certain features of the matrix are crucial for producing cell capsules and cell capsule tubes in the matrix. For example, the degree of polymerization, protein concentration and viscoelasticity of the matrix affect the production of cell capsules and cell capsule tubes. The present disclosure contemplates a wide range of matrix polymerization degrees from about 10% oligomerization to completely 100% polymerization. The matrix polymerization degree is also related to matrix density and viscoelasticity. In addition, proteins present in the matrix or subsequently added to the matrix also affect the production of cell capsules and cell capsule tubes. The present disclosure expects that the final protein concentration in the matrix is ​​a range of about 2-12 mg / ml. The present invention further contemplates a matrix in the pH 4-8 range. The degree of polymerization, gradient, density and viscoelasticity of the matrix affect the chemotaxis of cell migration in the matrix. In one embodiment, the 3D matrix is ​​Matrigel.

[0037] Cells disclosed herein include eukaryotic cells, animal cells, plant cells, including but not limited to insect cells of fruit fly cells, Caenorhabditis elegans (C.elegant) cells, etc. Exemplary cells include any cell, human or other cells, including diseased cells or healthy cells. Certain cells include human cells, non-human cells, human stem cells, differentiated cells, induced pluripotent stem cells (iPSCs), genetically modified cells, human pluripotent cells, epithelial cells, endothelial cells, immune cells, muscle cells, mouse stem cells, primary cell lines, immortalized cell lines, primary and immortalized fibroblasts, HeLa cells and neurons and tumor cells. In one embodiment, the cell is a mammalian cell. In another embodiment, the cell is a human mammary epithelial cell. In certain embodiments, the cell is an adult or embryonic stem cell. In one embodiment, the cell is a pluripotent stem cell. In another embodiment, the cell is an induced pluripotent stem cell. In yet another embodiment, the cell is a human induced pluripotent stem cell. According to certain aspects, the cell is in vitro, in vivo or in vitro.

[0038] According to another aspect, the present disclosure provides a method for producing cell capsules and cell capsule tubes. In one embodiment, the method comprises the following steps: implanting cells in a 3D matrix or its top layer, and incubating the 3D matrix implanted with cells at a temperature suitable for producing cell capsules and cell capsule tubes. The incubation temperature suitable for producing cell capsules and cell capsule tubes is about 37°C, and there are differences between specific cell types. In one embodiment, the 3D matrix is ​​frozen before implantation. In certain embodiments, implantation occurs at a temperature range of about 1-45°C, 1-37°C, 1-6°C, and 2-4°C. In other embodiments, the thickness of the 3D matrix is ​​in the range of about 1-1000 μm, 2-100 μm, 5-50 μm, and 5-10 μm.

[0039] According to certain aspects, the cell capsule and cell capsule tube surround the cells that produced the cell capsule and cell capsule tube. According to other aspects, the cell capsule and cell capsule tube allow the expulsion of the enclosed cells that produced the cell capsule and cell capsule tube. According to another aspect, the cell capsule and cell capsule tube allow multiple cells to enter from the surrounding environment.

[0040] According to one aspect, before the cells are implanted, they are present at a concentration of about 1×10-1×10 5 The density of cells / ml was presented as a single cell suspension.

[0041] The membranes of the cell capsule and the cell capsule tube have certain characteristics. According to one aspect, the membranes of the cell capsule and the cell capsule tube contain the plasma membrane protein Ca 2+ ATPase 2. According to another aspect, syncytin-1 regulates fusion of cell capsule tubes and cell entry. According to another aspect, growth factors regulate the generation of cell capsules and the development of cell capsule tubes. According to another aspect, ITGB-2 mediates cell migration in cell capsule tubes and regulates the elongation of cell capsule tubes. According to another aspect, matrix metalloproteinases mediate the elongation of cell capsule tubes.

[0042] In certain embodiments, the 3D matrix comprises bioactive and / or bioinactive agents, including but not limited to collagen, Matrigel matrix material, elastin, laminin, proteoglycans (such as heparan sulfate, chondroitin sulfate, and keratin sulfate), non-proteoglycans (e.g., hyaluronic acid), proteins (such as fibrils, Facit, short chains, and basement membrane proteins), and signaling proteins (such as FAK, talin, vinculin, paxillin, α-actinin, and GTPases).

[0043] According to another aspect, the present invention provides a method for producing cell capsules and cell capsule tubes in vitro. In one embodiment, the method comprises the following steps: implanting cells in a single cell suspension onto the top layer of a 3D matrix; culturing the implanted cells in a suitable culture medium and at a suitable temperature, wherein each single cell produces a cell capsule and a cell capsule tube in the 3D matrix.

[0044] According to another aspect, the present invention provides a method for preparing a 3D matrix suitable for producing cell capsules and cell capsule tubes. In one embodiment, the method comprises: freezing the 3D matrix and thawing the 3D matrix to a suitable temperature. The temperature suitable for thawing the matrix is ​​between about 1-45°C, 1-37°C, 1-6°C and 2-4°C. DETAILED DESCRIPTION

[0045] The following examples are provided to illustrate various embodiments of the present invention and are not intended to limit the present invention in any way. The examples of the present invention and the methods described herein are currently representatives of preferred embodiments, are exemplary, and are not intended to be limiting of the scope of the present invention. Those skilled in the art will appreciate variations therein and other uses contained within the spirit of the present invention as defined by the scope of the claims.

[0046] Example 1

[0047] Production of cell capsules and cell capsule tubes

[0048] To study the mechanisms of cell boundaries and 3D cell motility, normal primary human mammary epithelial cells (HMECs) were implanted into a 3D Matrigel matrix, which is a reconstructed extracellular matrix (ECM) substitute in certain embodiments of the present disclosure. Single spherical HMECs in 3D Matrigel, rather than cells in a 2D environment, produced round / irregular shapes and extracellular vesicular capsules that surrounded the cells and were of varying sizes ( Figure 1A Approximately 96% of single HMECs (1×10 in a 6-well plate) 3 cells / well, n=3) produced extracellular vesicles at 12 hours. The diameter / major axis of the extracellular spherical / ellipsoidal vesicles increased significantly and reached 250 μm. To confirm whether the vesicle surface was membranous, we transiently overexpressed enhanced green fluorescent protein (EGFP) and the plasma membrane protein Ca in HMECs. 2+ ATPase 2 fusion (EGFP-PMCA2). In fact, EGFP-PMCA2 is distributed in the cytoplasmic membrane and the extracellular membrane vesicle, confirming that the extracellular vesicle is surrounded by a membrane ( Figure 1A These extracellular vesicles can elongate to form long tubes of variable length ( Figure 1B Over time, individual vesicles decellularize spontaneously, leaving acellular and closed vesicles with taut membranes of various morphologies (spherical, ellipsoidal, or irregular). Figure 1C-1D These cysts come in a variety of sizes, up to 100 μm in diameter ( Figure 1E These cell capsules are membranous ( Figure 1F ). These observations demonstrated that the vesicle is located independently outside the plasma membrane and that cell-free vesicles can exist in the absence of cells. This previously unrecognized extracellular membrane-like vesicle produced by a single mammalian cell was called the vesicle.

[0049] Example 2

[0050] Decellularization of cell capsule

[0051] In most cases, cells were completely separated from their cell-free capsules after decellularization of the capsules. The cell-free capsules ruptured and formed deflated and concave discs ( Figure 1C ). Sometimes, decellularization of the capsule results in incomplete separation of the detached cells from their cell-free capsule.

[0052] After decellularization, the growth of cell-free cysts ceased, strongly suggesting that the generation and growth of cysts depend on the luminal cells. At the same time, the large gap / distance between the plasma membrane and the extracellular cysts suggests that cyst components derived from luminal cells are released / delivered to the outside of the plasma membrane for cyst construction ( Figure 1C ). Subsequently, the cell-free cyst continued to shrink and deflate, and the cyst membrane folded to form a large, shrunken and concave disc, or a short flat tube. After about 0.5-1h, the membrane of the cell-free cyst was degraded and the cyst self-disassembled. These observations suggest that the life cycle of the cyst proceeds through several consecutive and distinct stages: from initiation, growth, decellularization, deflation and shrinkage, membrane degradation to self-disassembly.

[0053] Cell contact at high cell density reduced the production of cell capsules and significantly increased the disassembly of cell capsules. Cell contact inhibition at high cell density could not completely inhibit the production of cell capsules or completely induce the disassembly of cell capsules. Cell contact at high cell density decreased the diameter growth of cell capsules.

[0054] Over time, single cells migrate bidirectionally within their capsules, deforming the capsule membrane and producing elongated capsules that form membrane tubes of variable length ( Figure 2 ). Then, the luminal cells detach from the cell capsule tube. Decellularization of the cell capsule tube produces acellular cell capsule tube. Then, the long acellular cell capsule tube automatically shrinks, and the membrane is severely folded to form deflated, coiled, twisted and membrane-condensed strands. Subsequently, the membrane of the long shrinked and acellular cell capsule tube is degraded, and then the capsule tube automatically disintegrates. These sequential developmental stages of the cell capsule tube of a single cell demonstrate that the life cycle of the cell capsule tube gradually proceeds from the migration of a single cell in its cell capsule to deformation of the cell capsule membrane, elongation of the cell capsule, formation of the cell capsule tube, decellularization and self-disintegration of the acellular capsule tube.

[0055] The length of the cell cyst tubes generated by a single HMEC can reach 820μm. Increasing cell density reduced the average cell cyst tube length, but not the average width (diameter / width was about 11μm). In addition, high cell density resulted in a shortened average lifespan of the cell cyst tubes. Moreover, high cell density reduced the average cell cyst tube density (length and number). Some cell cyst tubes can withstand dense microenvironments.

[0056] Next, we evaluated HMLER (CD44 high / CD24low ) FA Subpopulations of breast cancer stem cells (Yi T, et al. (2014) Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1 / CXCR4 in breast cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America 111 (21): E2182-2190) cell cyst formation. 2 and 1×10 3 At a low cell density of 10 cells / well, approximately 99% of BCSCs produced cell capsules in 3D Matrigel at 15h. BCSC cell capsules have a stronger ability to resist cell contact inhibition. BCSC cell capsule tubes are statistically longer than HMEC, and the length of a single BCSC cell capsule tube can reach 1000μm.

[0057] Example 3

[0058] The cell capsule and cell capsule tube are extra-plasma organelles

[0059] The inventors have found that cell capsules and cell capsule tubes are neither extensions of the plasma membrane nor connections to the cell surface. They are produced by individual cells, surrounded by their own generative membranes that are different from the plasma membrane, and surround the cells that produce them. In addition to pleiotropic biological functions, cell capsules and cell capsule tubes have unique features, including: extracellular membrane capsules (or capsule tubes) that wrap cells, and allow decellularization and cell entry. On the other hand, cell capsule tubes, rather than cell capsules, provide long tubular channels for the directional transport of multiple cells. Cell capsules and cell capsule tubes are not extensions of the plasma membrane, but extracellular membrane organelles that wrap cells. Cell capsules and cell capsule tubes do not exist in 2D cell cultures. Cell capsules and cell capsule tubes have pleiotropic biological functions, including providing support scaffolds and coverings for the wrapped cells, allowing cell decellularization and cell entry. Cells can migrate in cell capsules, cell capsule tubes, and cell capsule tube networks. The self-decomposition of cell capsules and cell capsule tubes does not affect the survival, proliferation, and growth of cells. Cell-free cell capsules and cell capsule tubes can exist for up to 98 hours. The cyst and cyst tube can accommodate multiple cells, such as dozens of cells. The cyst tubes are interconnected and form an open tubular network for directional cell translocation in multiple directions. These characteristics of the cyst and cyst tube indicate that they are two novel facultative organelles that are different from all previously described organelles.

[0060] Example 4

[0061] Formation of cell-vesicle network

[0062] At 6 h, single primary normal HMECs generated large, membranous, and short cell capsules in the specified Matrigel matrix ( Figure 2 At 10 h, HMEC migrated in short cell capsules and produced elongated cell capsules ( Figure 2 At 36h, multiple HMEC long cell capsules were connected to each other and formed a network through connecting nodes. Figure 2 At 68 h, HMECs aggregated and formed cell clusters, all HMEC cell capsules disintegrated and no cell capsules remained ( Figure 2 ).

[0063] At 4 h, breast cancer stem cells (BCSCs) have generated large and short cell capsules in the 3D Matrigel matrix as shown ( Figure 3A BCSCs migrate bidirectionally in the cell capsule tube, deforming the cell capsule membrane and forming a tubular morphology, and generating long and curved cell capsule tubes ( Figure 3B ). Multiple BCSC cell capsule tubes connected and formed various morphologies, including closed rings. Many cancer cells migrated into the cell capsule tubes in different forms, including streamlined and linear shapes (Figure 3). Afterwards, BCSCs aggregated and formed spherical or irregularly shaped tumor spheres. Next, we quantified the length of BCSC cell capsule tubes over time. BCSC cell capsule tubes can reach 1000μm in length. Multiple cell capsule tubes can connect to form longer tubes. The number of cell capsule tubes decreased over time, indicating that the length of cell capsule tubes is dynamic and strictly controlled ( Figure 4 ).

[0064] The above data indicate that cell cyst tubes usually proceed through consecutive but distinct stages: cell cyst initiation, cell migration in the cell cyst, cell cyst elongation and formation of cell cyst tubes, coordinated connection of multiple cell cysts and formation of networks, cell migration in the cell cyst tube network, cell aggregation and cell cluster / cluster formation, and cell cyst tube disassembly.

[0065] Two or more HMEC cell capsules of variable length are interconnected by connecting nodes and form a tubular network. At 38h, BCSC developed more cell capsule connection nodes than HMEC. In addition, the average number of cell capsules per connecting node of BCSCs is greater than that of HMEC. The cell capsule density of BCSC is about 3 times higher than that of HMEC. These data show that BCSC has a stronger ability to generate interconnected cell capsule networks. The lifespan of BCSC cell capsules with isolated or connected cells is much longer than that of cell-free BCSC cell capsules, indicating that cells in the lumen help maintain the capsule from decomposition. Compared with isolated BCSC cell capsules containing cells, BCSC cell capsules containing cells remain intact for a longer period of time. These results indicate that the maintenance of cell capsules is strictly controlled and mediated by cells in the lumen. Importantly, BCSC cell capsules are interconnected and form tubular networks in tumors in vivo, and multiple cells migrate in these tubular networks. These data demonstrate that the cell capsule network provides a membrane tubular mesh for the movement of directional cells in different directions.

[0066] Example 5

[0067] Cell-encapsulated tube traffic arteries for cell transport

[0068] Cells migrate in a network of membranous cell cysts, where the tubular cell cysts provide arterial traffic for cell translocation ( Figure 2 -3). Using rapid cell lysis and instant imaging techniques, we examined the cell cyst network architecture. BCSC cell cysts extensively and actively interconnected, significantly forming crosses, hollow circles, closed rings, and many other irregular morphologies, providing an ultra-large tubular network for cancer cell relocation to distal destinations in multiple directions ( Figure 4 ). Single and multi-cells migrate faster in the cell capsule than in a 3D environment. The cell capsule forms a traffic artery for directional 3D cell transport.

[0069] Example 6

[0070] Syncytin-1 regulates cell cyst fusion and cell entry

[0071] The cell capsules of different cells can fuse to form larger cell capsules, and cells can enter the cell capsules of other cells ( Figure 5A Cells can enter the cysts of other cells, resulting in a single large cyst containing multiple cells or clusters of cells ( Figure 5B-5C Next, we explored the molecular mechanisms of cyst tube fusion, merger, and cell entry. The endogenous membrane fusion protein syncytin-1 is expressed in HMECs, cysts, and cyst tubes. Transient knockout of syncytin-1 in HMECs significantly reduced cyst tube elongation and connection, but not cyst initiation ( Figure 5D-5F In addition, the level of syncytin-1 protein increases during cell tube elongation ( Figure 5G ). These data demonstrate that syncytin-1 regulates cell capsule fusion and cell entry.

[0072] Example 7

[0073] Integrin subunit β-2 (ITGB-2) promotes the development of cell cyst tubes

[0074] Integrins are cell surface support molecules that are essential for cell adhesion, attachment, migration, and invasion. We examined 26 integrin gene transcripts in BM-MSCs, HMECs, and BCSCs during tube development. ITGB-2 was significantly increased along the elongated tube ( Fig. 6A ). In addition, transient knockdown of ITGB-2 with gene-specific shRNA resulted in a significant reduction in the elongation of the cell cyst tube, whereas knockdown of ITGA-8 did not have this effect ( Figure 6B These data suggest that ITGB-2 mediates cell migration in the cyst tube and regulates the elongation of the cyst tube.

[0075] In summary, the present disclosure provides that a single cell produces two new organelles, an extracellular and membranous cell capsule and a cell capsule tube, and the cell capsule tube provides a tubular traffic artery for 3D cell transport. Cell movement in multicellular organisms is crucial for embryonic development, tissue formation, organ homeostasis, immune response, wound healing, tissue regeneration and tumor metastasis.

[0076] The generation and development of cysts and tubes are highly dependent on the 3D environment and cellular activities, and in research, they have only become the focus when the biochemical, biophysical, and biomechanical characteristics of the 3D matrix (such as polymerization, density, and viscoelasticity) are precisely controlled. The spatiotemporal manifestation, self-degradation, and self-disassembly of cysts and tubes have helped to solve the difficult problems of realizing and identifying these previously uncharacterized organelles.

[0077] The cell capsule membrane provides a large amount of biomembrane skeleton that supports cell adhesion, attachment, detachment, morphological transformation and movement plasticity. On the other hand, the cell capsule wraps the cells, physically shielding them from the extracellular microenvironment, prompting the strict spherical cells to transform into loose irregular forms, and can be used as a protective covering against environmental stress. The cell capsule tube provides a membrane tube that adapts to the directional migration and bidirectional movement of multiple cells. More importantly, the cell capsule tubes are interconnected and form a tubular network, which significantly increases the direction of cell migration, amplifies the cell diffusion area, and enhances the efficiency of directional 3D cell migration. Although cell contact inhibition at high cell density reduces the generation of cell capsules, increases the decomposition of cell capsules, and reduces the duration of cell capsule tubes, there are still about 1.2‰ of normal cells (HMECs) and up to 1.1% of breast cancer stem cells that produce cell capsules and produce long capsule tubes for the directional migration of multiple cells. Therefore, a model in which a small fraction of cells generate homogenous membranous cysts and provide arteries for directional transport of multiple cells is an effective model, or at least an alternative model, compared to a model in which all cells are inevitably exposed to and experience heterogeneous barriers from the tight and heterogeneous 3D ECM and cells in vivo. Cytocysts and cysts have the potential for pleiotropic biological functions, and more work is needed to elucidate their other functions.

[0078] The enlargement of cell capsule depends on the activity of intraluminal cells and the termination of growth of cell-free cell capsule. On the other hand, cell-free cell capsule and cell capsule tube carry out rapid automatic degradation and self-decomposition. In addition to intracellular organelles, eukaryotic cells also include extracellular organelles released or falling off to microenvironment, such as exosomes (Keller S, Sanderson MP, Stoeck A, & Altevogt P (2006) Exosomes: from biogenesis and secretion to biological function. Immunology letters 107 (2): 102-108). Interestingly, there are many different single-layer membrane-enclosed vesicles in the cell capsule lumen. Therefore, these membrane vesicles can be functionally connected to the carrier or cargo of the cell capsule component of delivery / shuttle cell origin, and connected to the container comprising lysate, and the release of the lysate can cause the strict control of cell capsule and cell capsule tube.

[0079] After decellularization, the phenomenon of cell-free cell capsule tube shrinking, shrinking, deflated, shortening, twisting and folding is consistent with the lack of luminal scaffolding in the cell capsule tube. The lack of microfilament network in the cell capsule tube lumen is consistent with the active migration of single cells and multiple cells in the cell capsule tube. On the other hand, the presence of microfilament skeleton in the cell capsule tube membrane is consistent with the fact that long cell capsule tubes can be dragged by cells to cross the ECM surface without breakage, interruption or entrapment.

[0080] Migration of cells in the cyst drives deformation and elongation of the cyst membrane, as well as formation and elongation of the cyst tube. Building membranes and other components in the cyst and cyst tube requires a large number of different proteins, suggesting that mRNA translation and / or protein biosynthesis are essential for the development of the cyst and cyst tube.

[0081] In conclusion, the two novel cell capsules and cell capsule tube organelles discovered in this study present pleiotropic biological functions, including providing tubular pathways and networks for cell trafficking, relocation, and migration, which may provide insights into understanding the mechanisms of cell protection and cell relocation involved in disease development and pathogenesis, including tumor metastasis.

[0082] Example 8

[0083] Materials and methods

[0084] Cells and reagents were purchased from ATCC (PCS-600-010 TM ) Primary normal human mammary epithelial cells (HMEC) were ordered from . HMLER (CD44 high / CD24 low ) FA BCSCs of subpopulation cells (27). FITC-conjugated anti-CD44 (BD Biosciences; G44-26) antibody and phycoerythrin-conjugated anti-CD24 (BD Biosciences, ML15) antibody were used for cell sorting by flow cytometry. MEGM TM Mammary Epithelial Cell Growth Medium BulletKit TM (Clonetics TM MEGM TM Mammary Epithelial Cell Growth Medium Plus SingleQuots TM The kit was purchased from Lonza (CC-3150). Matrigel TM Membrane matrix (CB-40234) was purchased from Corning. BD Matrigel matrix growth factor reduced (GFR, catalog number 356230) was purchased from BD Bioscience.

[0085] Time-lapse DIC microscopy, transient transfection, real-time quantitative PCR, and transient gene knockout. Time-lapse DIC (differential interference contrast) microscopy analysis of cell capsule elongation and cell migration was performed using a Nikon Ti motorized inverted microscope and a digital Hamamatsu ORCA-ER cooled CCD camera with a 20× lens. HMEC cultures with cell capsules in Matrigel matrix (>40 μm depth) were analyzed by TEM. 2000 EGFP-hPMCA2z / b (Addgene, #47584) and / or mCherry-β-actin (#54967) plasmids were co-transfected into HMEC. Gene-specific primers (IDT) and iQ Real-time quantitative PCR was performed using Bio-Rad Green Supermix and 7900HT fast real-time PCR.

[0086] Reagents and antibodies. Plasmids of EGFP-hPMCA2z / b (#47584) and mCherry-β-actin (#54967) were purchased from Addgene. Anti-GAPDH (Catalog No. 2118S, 1:1000 dilution in Western blot analysis) antibody was ordered from Cell Signaling Technology. DAPI (4,6-diamidino-2-phenylindole, dihydrochloride, 1:1000 dilution in immunofluorescence assay) was ordered from KPL. Anti-γ-actin (γ-actin, monoclonal, ab123034, 1:1000 dilution in immunofluorescence assay), anti-pan-cadherin (polyclonal, ab140338, 1:1000 dilution in immunofluorescence assay) antibodies were purchased from Abcam.

[0087] Transient transfection. HMEC were cultured with MEGM at 37°C in a humidified atmosphere of 5% CO2. Plasmids EGFP-hPMCA2z / (Addgene, #47584) and / or mCherry-β-actin (#54967) were co-transfected into HMECs using ELISA 2000 (Life Technologies, #11668027). Two days after transfection, cells were used for assays.

[0088] The development of cell capsule and cell capsule tube. HMEC (with or without transfection), BM-MSC and HMLER (CD44 high / CD24 low ) FA BCSCs of subpopulations were cultured at the indicated cell densities in MEGM medium (or 5 × 10 in 6-well plates). 2cells / well, or 1.2 × 10 in a 10 cm dish 4 Cells, if not specified) were seeded on a Matrigel matrix layer. A 3D Matrigel layer (>40 μm deep) was prepared by quickly adding frozen and thawed Matrigel matrix (thawed on ice overnight in a 4°C cold room, protein concentration of 4-12 mg / ml) to a pre-cooled 6-well plate (with / without a cold micro-coverslip). Cold MEGM (4°C) was then added and cultured in a hood at room temperature (25°C) for 5-25 minutes. The cells were then implanted onto the surface of the 3D Matrigel gel and cultured in a humidified incubator (37°C, 5% CO2). The cells entered (or invaded) the Matrigel gel in variable layers and produced cell capsules and cell capsule tubes. Cell capsules and cell capsule tubes at different stages of development were used in this study.

[0089] Time-lapse DIC microscopy and video. Time-lapse DIC (differentiation interference contrast) microscopy analysis of cell capsule elongation and cell migration was performed using a Nikon Ti motorized inverted microscope and a digital Hamamatsu ORCA-ER cooled CCD camera with a 20× lens. The time-lapse microscope was equipped with DIC, phase contrast and epi-fluorescence optics (Prior Proscan III motorized stage) and shutters (a perfect focus system) and an OkoLab 37°C, 5% CO2 cage microscope incubator (OKOLab). Images were taken every 30 seconds over the course of 10 to 36 hours. All images were obtained using MetaMorph software. Tracks generated by 2 hours of cell capsule elongation were obtained using MetaMorph and ImageJ software. The elongation speed of the cell capsule was also calculated using length and time measurements. Videos were prepared using images collected by time-lapse and MetaMorph software (15 frames per second, fps).

[0090] Image acquisition. Differential interference contrast (DIC) and fluorescence images of fixed cells (with and without capsules) were acquired using an 80i upright microscope and a digital Hamamatsu ORCA-ER cooled CCD camera with a 20× or 40× lens. Bright-field phase contrast images were acquired using a Nikon digital camera. The capsule initiation rate / high performance field (HPF, 200×) and the number of elongated capsules / HPF were quantified. All images were acquired using MetaMorph image acquisition software and analyzed with ImageJ software.

[0091] Total RNA extraction and real-time quantitative PCR. HMEC and BCSC with and without detectable cell capsules (1.2 × 10 per 10 cm dish) were extracted (Thermo Fisher Scientific)4 The samples used were plated on a Matrigel matrix layer (about 10 μm thick). Total RNA was extracted as described in the instructions. Gene-specific primers (IDT), iQ Quantitative real-time PCR assays were performed using Bio-Rad Green Supermix and 7900HT Fast Real-Time PCR. GAPDH was used as a control and three independent experiments were performed. Data analysis and heatmap data were calculated and prepared as described previously.

[0092] Western Blotting. HMECs and BCSCs (1.2 × 10 cells / 10 cm dish) were isolated from HMECs and BCSCs at the indicated times using radioimmunoprecipitation assay (RIPA) buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) and protease inhibitors (Roche). 4 Total protein was extracted from 10% or 12% SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride fixed TM -P membrane. Incubate the polyvinylidene difluoride membrane with primary antibody (Anti-GAPDH (Cell signaling Technology, 2118, 1:1000) at 4°C for 4 hours, then wash in 0.1% Tween / TBS. Incubate the membrane with appropriate peroxidase-conjugated secondary antibody at 25°C for 1 hour, wash three times before detecting the signal, and use ECL TM Western blotting detection reagents were developed.

[0093] Quantification and statistical analysis

[0094] In all figures: not significant, ns, P>0.05; *P<0.05; **P<0.01; ***P<0.001.

[0095] Other embodiments will be apparent to those skilled in the art. It should be understood that the foregoing description is provided for clarity only and is exemplary only. The spirit and scope of the present invention are not limited to the above examples, but are included in the claims. All publications and patent applications cited above are incorporated herein by reference in their entirety for all purposes, to the same extent as if each individual publication or patent application was specifically indicated to be incorporated herein by reference.

Claims

1. A composition comprising a 3D matrix and a cell capsule and a cell capsule tube.

2. The composition according to claim 1, characterized in that The cell capsules and cell capsule tubes are produced by single cells implanted into the top layer of the 3D matrix; And / or, the cell capsule and the cell capsule tube surround the cells that produce the cell capsule and the cell capsule tube; And / or, the cell capsule and the cell capsule tube further include a plurality of cells entering the cell capsule and the cell capsule tube from the surrounding environment; And / or, the cell capsule and cell capsule tube do not contain cells; and / or, the 3D matrix is ​​biodegradable; And / or, the 3D matrix comprises elastin, laminin, collagen, proteoglycan or non-proteoglycan.

3. The composition according to claim 2, characterized in that The proteoglycans include heparan sulfate, chondroitin sulfate and keratin sulfate; And / or, the non-proteoglycan comprises hyaluronic acid.

4. The composition according to claim 1, characterized in that The 3D matrix also includes fibrin, Facit protein, short chain protein and basement membrane protein; and / or, the 3D matrix further comprises signaling proteins comprising focal adhesion kinase (FAK), talin, vinculin, paxillin, α-actinin, and GTPase; and / or, the 3D matrix is ​​Matrigel; And / or, the polymerization, density, protein concentration and viscoelasticity of the 3D matrix affect the generation of the cell capsule and cell capsule tube.

5. A method for producing cell capsules and cell capsule tubes, comprising: seeding cells into the top layer of the 3D matrix, and The cell-implanted 3D matrix is ​​incubated under conditions that allow the cells to generate the cell capsules and cell capsule tubes.

6. The method according to claim 5, characterized in that The cell-seeded 3D matrix is ​​incubated at a temperature of about 4°C to about 37°C; and / or, keeping the 3D matrix frozen prior to implantation; and / or, implantation occurs between about 2-6°C; and / or, the 3D matrix is ​​biodegradable; and / or, the 3D matrix comprises elastin, laminin, collagen, proteoglycan or non-proteoglycan; and / or, the proteoglycans include heparan sulfate, chondroitin sulfate and keratin sulfate; and / or, the non-proteoglycans include hyaluronic acid; and / or, the 3D matrix further comprises proteins, including fibrin, Facit protein, short chain protein and basement membrane protein; and / or, the 3D matrix further comprises signaling proteins comprising focal adhesion kinase (FAK), talin, vinculin, paxillin, α-actinin, and GTPase; and / or, the 3D matrix is ​​Matrigel; and / or, the polymerization, density, protein concentration and viscoelasticity of the 3D matrix affect the generation of the cell capsule and cell capsule tube; And / or, the 3D matrix has a thickness between about 3 and about 100 μm.

7. The method according to claim 5, characterized in that The cell capsule and the cell capsule tube surround the cells producing the cell capsule and the cell capsule tube; and / or, the cell capsule and the cell capsule tube allow the detachment of the enclosed cells, and the cells produce the cell capsule and the cell capsule tube; and / or, the cell capsule and the cell capsule tube allow a plurality of cells to enter from the surrounding environment; and / or, the cells are present at a concentration of about 1×10 to about 1×10 5 The density of cells / ml was presented as a single-cell suspension; And / or, the membrane of the cell capsule and the cell capsule tube comprises plasma membrane protein Ca 2+ ATPase 2; and / or, syncytin-1 regulates cell capsule fusion and cell entry; and / or, ITGB-2 mediates cell migration in the cell cyst tube and regulates the elongation of the cell cyst tube; and / or, the polymerization, protein concentration, durotaix, density and viscoelasticity of the 3D matrix; And / or, the 3D matrix further comprises biologically active and / or biologically inactive agents.

8. The method according to claim 5, characterized in that The cells include mammalian cells, insect cells or C.elegant cells; And / or, the mammalian cell is a human cell; preferably, the human cell is a human mammary epithelial cell; and / or, the cells include differentiated cells, iPS cells, genetically modified cells, human pluripotent cells, epithelial cells, endothelial cells, immune cells, muscle cells, mouse stem cells, primary cell lines, immortalized cell lines, primary and immortalized fibroblasts, HeLa cells and neurons and tumor cells; And / or, the cells are implanted on the top surface of the 3D matrix.

9. A method for producing cell capsules and cell capsule tubes in vitro, comprising the following steps: Cells from a single cell suspension are seeded onto the top layer of the 3D matrix; and The cell-implanted 3D matrix is ​​cultured under conditions that allow the cells to generate cell capsules and cell capsule tubes in the 3D matrix.

10. A method for preparing a 3D matrix suitable for producing cell capsules and cell capsule tubes, comprising: freezing the 3D matrix, and Thaw the 3D matrix at 2-6°C.